1. Cellular immunotherapy for leukemia
   Norimitsu Kadowaki et al, 2013, Drug Delivery System CrossRef
2. Dendritic Cells of Leukemic Origin: Specialized Antigen-Presenting Cells as Potential Treatment Tools for Patients with Myeloid Leukemia
   Daniel Christoph Amberger et al, 2020, Transfusion Medicine and Hemotherapy CrossRef
3. A Causal Role for the Human Tumor Antigen Preferentially Expressed Antigen of Melanoma in Cancer
   Mirjam T. Epping et al, 2006, Cancer Research CrossRef
4. Development of an Automated Viral Plaque Assay Program and ELISpot Counting Program on 96-Well Plate Platform
   Suphanut Plengkham et al, 2022, 2022 International Conference on Electrical, Computer and Energy Technologies (ICECET) CrossRef
5. Theory and Practice of Immunotherapy Directed against the PRAME Antigen
   V.A. Misyurin, 2018, Clinical oncohematology CrossRef
6. Automate platform for Capturing and Counting ELISpot on 96-Well Plate
   Chayatorn Kukiattikoon et al, 2021, 2021 International Conference on Engineering and Emerging Technologies (ICEET) CrossRef
7. Quantification of ex vivo generated dendritic cells (DC) and leukemia-derived DC contributes to estimate the quality of DC, to detect optimal DC-generating methods or to optimize DC-mediated T-cell-activation-procedures ex vivo or in vivo
   H M Schmetzer et al, 2007, Leukemia CrossRef
8. Identification of Human Aldehyde Dehydrogenase 1 Family Member A1 as a Novel CD8+ T-Cell–Defined Tumor Antigen in Squamous Cell Carcinoma of the Head and Neck
   Carmen Visus et al, 2007, Cancer Research CrossRef